Elucidating pathophysiological mechanisms of asthma COPD ovarlap(ACO) in terms of oxidative and nitrative stress and the applicability to the individualized therapy for ACO

Elucidating pathophysiological mechanisms of asthma COPD ovarlap(ACO) in terms of oxidative and nitrative stress and the applicability to the individualized therapy for ACO - Elucidating pathophysiological mechanisms of asthma COPD ovarlap(ACO) in terms of oxidative and nitrative stress and the applicability to the individualized therapy for ACO

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025329

Enrollment

150

Registered

2016-12-19

Start date

2014-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma COPD ovarlap:ACO,asthma,COPD

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ACO,asthma and COPD patients diagnosed by spirometry and respiratory physician and healthy volunteers

Exclusion criteria

Exclusion criteria: patients and healthy volunteers who deny participating in this study

Design outcomes

Primary

Measure	Time frame
Measure and evaluate oxidative and nitrateve stress of ACO,asthma,COPD and healthy subjects.	—

Countries

Japan

Contacts

Public ContactTomohiro Ichikawa

Tohoku University Graduate School of Medicine Department of Respiratory Medicine

ichikawa@rm.med.tohoku.ac.jp022-717-8539

Outcome results